HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $237,000 | -79.0% | 6,000 | -78.6% | 0.04% | -58.1% |
| Q4 2021 | $1,126,000 | +22.0% | 28,002 | +23.4% | 0.09% | +30.3% |
| Q3 2021 | $923,000 | -59.2% | 22,701 | -81.9% | 0.07% | -63.1% |
| Q1 2020 | $2,260,000 | +30.2% | 125,603 | +28.3% | 0.18% | +67.3% |
| Q4 2019 | $1,736,000 | +26.6% | 97,934 | +10.8% | 0.11% | +32.1% |
| Q3 2019 | $1,371,000 | -9.7% | 88,400 | 0.0% | 0.08% | -10.0% |
| Q2 2019 | $1,519,000 | +6.7% | 88,400 | -0.0% | 0.09% | +12.5% |
| Q1 2019 | $1,424,000 | -59.6% | 88,431 | -63.3% | 0.08% | -59.4% |
| Q4 2018 | $3,524,000 | -25.5% | 240,880 | -7.5% | 0.20% | +0.5% |
| Q3 2018 | $4,732,000 | -20.4% | 260,444 | -26.1% | 0.20% | -13.3% |
| Q2 2018 | $5,943,000 | -14.2% | 352,300 | -0.3% | 0.23% | -3.4% |
| Q1 2018 | $6,923,000 | -16.9% | 353,389 | -14.0% | 0.23% | -3.3% |
| Q4 2017 | $8,327,000 | +1167.4% | 411,019 | +1312.6% | 0.24% | +1323.5% |
| Q2 2015 | $657,000 | +33.0% | 29,096 | -25.2% | 0.02% | +41.7% |
| Q1 2014 | $494,000 | – | 38,899 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |